U.S. inspections of Canadian drug companies reveal systemic problems that have put Canadian patients at risk.
North American patients have been put at risk by prescription drugs that Canadian pharmaceutical companies sold with knowledge that their products were defective, a Star investigation has found.
Using records obtained through U.S. freedom of information laws, the Star also found other Canadian companies have:
Since 2008, more than 40 Canadian drug companies, including Toronto-based generic giant Apotex, have been cited for serious manufacturing violations.
All of these violations are detailed in inspection reports provided to the Star not by Health Canada but the American Food and Drug Administration (FDA), which also inspects Canadian facilities.
The Star investigation found that while the FDA strictly and transparently enforces drug manufacturing laws, Health Canada leaves Canadians in the dark by keeping secret details of problems its inspectors find.
Read more: http://www.thestar.com/news/canada/2014/09/11/canadians_kept_in_dark_about_defective_drugs.html
Read more: http://www.thestar.com/news/canada/2014/09/11/canadians_kept_in_dark_about_defective_drugs.html
No comments:
Post a Comment